Frank T. Cary

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Lincare Holdings, Inc. supplies and distributes home respiratory equipment and services. It offers home oxygen equipment, other respiratory therapy and home infusion therapy. The firm also offer medical equipment, such as hospital beds, wheelchairs and other medical supplies to the home health care market. The company was founded in 1990 and is headquartered in Clearwater, FL.

Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA.

ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.

Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT.

Lexmark International, Inc. engages in the provision of imaging solutions and technologies. It includes managed print, cloud, hardware warranty and repair, and professional services. The firm also offers cloud, security, print, capture, and software partners solutions to industries such as banking, government, healthcare, insurance, education, manufacturing, and retail. The company was founded in 1991 and is headquartered in Lexington, KY.